A retrospective review of the pre-testing and vaccination using the Q VAX vaccine in Australian meat processor and livestock workers from 2002.

Not Applicable

Completed

• Conditions: Q Fever; Infection - Other infectious diseases; Public Health - Health service research

• Registration Number: ACTRN12616000161426
• Lead Sponsor: Seqirus Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 138000

Inclusion Criteria

Completion of Q Fever Register Consent form

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine whether results from serology testing contribute additional information needed to confirm the decision to vaccinate with Q VAX. This will be done by a review of the individuals details, skin and serology test results contained in the Q Fever Registry. [Prior to vaccination with Q VAX]

Secondary Outcome Measures

Name	Time	Method
To assess the relationship between skin test results and serology results. This will be done by a review of the individuals details, skin and serology test results contained in the Q Fever Registry. [Prior to vaccination with Q VAX];To determine the percentage of participants in the Register who received vaccination with Q VAX. This will be done by a review of the individuals details, skin and serology test results contained in the Q Fever Registry. [At the time of Q VAX vaccination]